Shares of Histogen Inc. (NASDAQ:HSTO – Get Free Report) dropped 3.4% during trading on Friday . The company traded as low as $0.21 and last traded at $0.21. Approximately 565 shares traded hands during trading, a decline of 95% from the average daily volume of 11,479 shares. The stock had previously closed at $0.22.
Histogen Trading Down 3.4 %
The firm’s fifty day simple moving average is $0.22 and its two-hundred day simple moving average is $0.27. The company has a market capitalization of $896,700.00, a price-to-earnings ratio of -0.07 and a beta of 1.20.
Histogen Company Profile
Histogen Inc, a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases.
Further Reading
- Five stocks we like better than Histogen
- Want to Profit on the Downtrend? Downtrends, Explained.
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- How to Calculate Inflation Rate
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- Best Aerospace Stocks Investing
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Histogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Histogen and related companies with MarketBeat.com's FREE daily email newsletter.
